share_log

Clarus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James E. Thomas(0.2%),Thomas, McNerney & Partners, LLC(0.1%), etc.

Apr 21, 2022 20:43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more